Shingles is a viral infection which produces a painful blistered rash. It is more common, and symptoms can be more severe, with advancing age.
The Shingles vaccination programme has recently been extended. In the past it was only available for those aged 70-79 years. It is planned that this will be made available over the next 10 years to those aged 60- 69 years. Public Health have given guidance regarding specific age cohorts who are eligible to be invited each year to catch up with this younger cohort. Details are below.
There are 2 types of Shingles vaccine:
a) The vaccine which has been used in the vaccination programme until now is a live vaccine (Zostavax). It is not suitable for anyone whose immune system is weakened. It is a one dose schedule.
b) A newer vaccine has now become available. It is inactivated (Shingrix) and requires 2 doses for full protection.
Who is eligible for Shingles vaccination?
Public Health have advised that the following groups are eligible for Shingles vaccination from September 2023:
Pneumococcal vaccination is a vaccine which protects against pneumonia, meningitis and other serious illnesses. This is usually a 'once in a lifetime' vaccination for all those aged 65 and over, and patients with certain conditions such as heart disease, COPD, diabetes or immune suppression. A small cohort of patients require a dose every 5 years (for example patients who have had a splenectomy, poor kidney function or who have coeliac disease)
We will be offering our 65 year olds both pneumococcal and shingles vaccination.
Those who are eligible will receive a booking link for our vaccination clinics in Cherryvalley Group Practice. If you believe you are due pneumococcal vaccination and have not been called, please speak with a member of our Reception team.